(19)
(11) EP 1 373 547 A1

(12)

(43) Date of publication:
02.01.2004 Bulletin 2004/01

(21) Application number: 02725443.2

(22) Date of filing: 27.03.2002
(51) International Patent Classification (IPC)7C12P 39/00, C12P 21/04
(86) International application number:
PCT/US2002/009998
(87) International publication number:
WO 2002/076578 (03.10.2002 Gazette 2002/40)
(84) Designated Contracting States:
AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR
Designated Extension States:
AL LT LV MK RO SI

(30) Priority: 27.03.2001 US 279026 P

(71) Applicant: SmithKline Beecham Corporation
King of Prussia, PA 19406 (US)

(72) Inventors:
  • DEVRIES, Ruth, L.
    King of Prussia, PA 19406 (US)
  • VICKROY, Thomas, B.
    King of Prussia, PA 19406 (US)

(74) Representative: Giddings, Peter John, Dr. 
GlaxoSmithKlineCorporate Intellectual Property (CN9.25.1)980 Great West Road
Brentford,Middlesex TW8 9GS
Brentford,Middlesex TW8 9GS (GB)

   


(54) CONTROL OF GLYCOFORMS IN IGG